CK0492B is a novel biaminourea antibiotic that targets bacterial plaque formation. Demonstrating significant antiplaque properties in vitro, it has also shown efficacy in reducing dental disease symptoms in an experimental mouse model. A 12-week study conducted in beagles highlighted its effectiveness in decreasing plaque and gingivitis while assessing its safety profile. The selection of canine subjects is informed by the similarities in periodontal disease onset and progression between dogs and humans, with chlorhexidine acetate serving as a positive control for comparison.
CK0492B is a novel biaminourea antibiotic that targets bacterial plaque formation. Demonstrating significant antiplaque properties in vitro, it has also shown efficacy in reducing dental disease symptoms in an experimental mouse model. A 12-week study conducted in beagles highlighted its effectiveness in decreasing plaque and gingivitis while assessing its safety profile. The selection of canine subjects is informed by the similarities in periodontal disease onset and progression between dogs and humans, with chlorhexidine acetate serving as a positive control for comparison.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: